Thermo Fisher Scientific (NY:TMO)

654.80 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

34 35 Next >

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

November 13, 2024

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

Via News Direct

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets

November 12, 2024

From Mainz BioMed NV

Via GlobeNewswire

Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024

November 11, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Market Whales and Their Recent Bets on TMO Options ↗

October 28, 2024

Via Benzinga

Earnings Outlook For Thermo Fisher Scientific ↗

October 22, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today ↗

October 07, 2024

Via Benzinga

(TMO) - Analyzing Thermo Fisher Scientific's Short Interest ↗

October 07, 2024

Via Benzinga

Thermo Fisher Scientific Declares Quarterly Dividend

November 07, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today ↗

November 05, 2024

Via Benzinga

Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert ↗

October 23, 2024

Via Benzinga

Thermo Fisher Scientific (TMO) Q3 2024 Earnings Call Transcript ↗

October 23, 2024

TMO earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Thermo Fisher Scientific Sails Through Q3 With Mixed Earnings, CEO Says In Great Position To Deliver 2024 Objectives ↗

October 23, 2024

Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped year-over-year. Guidance for 2024 remains reaffirmed.

Via Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today ↗

September 24, 2024

Via Benzinga

Is NYSE:TMO suited for quality investing? ↗

September 10, 2024

Analyzing the Quality Characteristics of THERMO FISHER SCIENTIFIC INC (NYSE:TMO).

Via Chartmill

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today ↗

September 09, 2024

Via Benzinga

Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday? ↗

October 23, 2024

Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest...

Via Benzinga

Thermo Fisher Scientific Reports Third Quarter 2024 Results

October 23, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity ↗

September 05, 2024

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

October 11, 2024

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.

Via Benzinga

Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses ↗

October 04, 2024

Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization...

Via Benzinga

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. ↗

October 03, 2024

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Via Investor's Business Daily

Topics Stocks

Industry Leader Thermo Fisher's Contract Services Positioned For Growth Amid Popular Demand For GLP-1 Weight Loss Drugs, Analyst Initiates With Long-Term Growth Potential ↗

October 01, 2024

Stephens initiated coverage on Thermo Fisher Scientific with an Overweight rating and $680 price target. The firm highlights the company's biopharma expansion, M&A strategy, and key growth areas like...

Via Benzinga

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024

October 01, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential”

September 24, 2024

Via AB Newswire

Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements

September 23, 2024

Via AB Newswire

Thermo Fisher Scientific Hosts 2024 Investor Day

September 19, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Momentum Investing Gives You An Edge, Until It Doesn’t ↗

September 17, 2024

Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system.

Via Talk Markets

Thermo Fisher Scientific Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

September 16, 2024

Via Benzinga

Time To Invest And Or Trade In Bio-Tech Stocks? ↗

September 13, 2024

Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help...

Via Talk Markets

Topics ETFs

Agilent Technologies Thrives From the Forever Chemicals Crackdown

September 05, 2024

Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets.

Via MarketBeat

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.